MedTrace Logo

Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment

NCT02599506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2018-10-01

No results posted yet for this study

Summary

This pilot study concentrates on studying the trajectory of breast cancer patient's fear of recurrence (FoR) over the course of radiation therapy. The aim is to collect repeated ratings of 100 breast cancer patient's FoR over the course of their treatment. It is hypothesized that cancer patient's FoR level will rise on nearing the termination of the in radiotherapy treatment, and radiotherapist-patient interaction modifies the development of patient's FoR.

Conditions

Sponsors & Collaborators

  • NHS Lothian

    collaborator OTHER_GOV

  • University of St Andrews

    lead OTHER

Principal Investigators

  • Gerald M Humphris, PhD · University of St Andrews

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2016-06-01
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02599506 on ClinicalTrials.gov